![Robert R. Goodwin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert R. Goodwin
Corporate Officer/Principal bei Takeda Vaccines (Montana), Inc.
Aktive Positionen von Robert R. Goodwin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Takeda Vaccines (Montana), Inc.
![]() Takeda Vaccines (Montana), Inc. Pharmaceuticals: MajorHealth Technology Takeda Vaccines (Montana), Inc. operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases. It specializes in developing vaccines against norovirus, influenza, and respiratory syncytial virus. The firm develops norovirus VLP vaccines that mimic the surface configuration of the live virus without the ability to cause infection, respiratory syncytial virus vaccine that mediates cell entry in its native form for use in anthrax treatment. The company was founded by Robert F. Bargatze on March 13, 2008 and is headquartered in Bozeman, MT. | Corporate Officer/Principal | - | - |
Karriereverlauf von Robert R. Goodwin
Ehemalige bekannte Positionen von Robert R. Goodwin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LigoCyte Pharmaceuticals, Inc. | Geschäftsführer | 01.01.2000 | 16.04.2014 |
Präsident | 01.01.2000 | 16.04.2014 | |
STS Biopolymers, Inc.
![]() STS Biopolymers, Inc. Industrial SpecialtiesProcess Industries Part of Angiotech Pharmaceuticals, Inc., STS Biopolymers, Inc. develops, manufactures, and licenses custom polymer-based coatings for medical devices. The company is based in Henrietta, NY. STS Biopolymers was acquired by Angiotech Pharmaceuticals, Inc. on December 04, 2003 for $23 million. | Corporate Officer/Principal | - | - |
Rochester Christian University | Corporate Officer/Principal | - | - |
Ausbildung von Robert R. Goodwin
University of California, Los Angeles | Undergraduate Degree |
University of Utah | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Corporate Officer/Principal | 3 |
Undergraduate Degree | 2 |
Chief Operating Officer | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
LigoCyte Pharmaceuticals, Inc. | Health Technology |
STS Biopolymers, Inc.
![]() STS Biopolymers, Inc. Industrial SpecialtiesProcess Industries Part of Angiotech Pharmaceuticals, Inc., STS Biopolymers, Inc. develops, manufactures, and licenses custom polymer-based coatings for medical devices. The company is based in Henrietta, NY. STS Biopolymers was acquired by Angiotech Pharmaceuticals, Inc. on December 04, 2003 for $23 million. | Process Industries |
Takeda Vaccines (Montana), Inc.
![]() Takeda Vaccines (Montana), Inc. Pharmaceuticals: MajorHealth Technology Takeda Vaccines (Montana), Inc. operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases. It specializes in developing vaccines against norovirus, influenza, and respiratory syncytial virus. The firm develops norovirus VLP vaccines that mimic the surface configuration of the live virus without the ability to cause infection, respiratory syncytial virus vaccine that mediates cell entry in its native form for use in anthrax treatment. The company was founded by Robert F. Bargatze on March 13, 2008 and is headquartered in Bozeman, MT. | Health Technology |
- Börse
- Insiders
- Robert R. Goodwin
- Erfahrung